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The incidence of the autoimmune disease, type 1 diabetes (T1D), has increased
dramatically over the last half century in many developed countries and is particularly high
in Finland and other Nordic countries. Along with genetic predisposition, environmental
factors are thought to play a critical role in this increase. As with other autoimmune
diseases, the gut microbiome is thought to play a potential role in controlling progression
to T1D in children with high genetic risk, but we know little about how the gut microbiome
develops in children with high genetic risk for T1D. In this study, the early development
of the gut microbiomes of 76 children at high genetic risk for T1D was determined
using high-throughput 16S rRNA gene sequencing. Stool samples from children born
in the same hospital in Turku, Finland were collected at monthly intervals beginning at
4–6 months after birth until 2.2 years of age. Of those 76 children, 29 seroconverted to
T1D-related autoimmunity (cases) including 22 who later developed T1D, the remaining 47
subjects remained healthy (controls). While several significant compositional differences
in low abundant species prior to seroconversion were found, one highly abundant
group composed of two closely related species, Bacteroides dorei and Bacteroides
vulgatus, was significantly higher in cases compared to controls prior to seroconversion.
Metagenomic sequencing of samples high in the abundance of the B. dorei/vulgatus
group before seroconversion, as well as longer 16S rRNA sequencing identified this group
as Bacteroides dorei. The abundance of B. dorei peaked at 7.6 months in cases, over
8 months prior to the appearance of the first islet autoantibody, suggesting that early
changes in the microbiome may be useful for predicting T1D autoimmunity in genetically
susceptible infants. The cause of increased B. dorei abundance in cases is not known but
its timing appears to coincide with the introduction of solid food.
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INTRODUCTION
Type 1 diabetes (T1D) is an autoimmune disorder typically devel-
oping within the first 5–6 years of life, beginning with inflamma-
tion of the pancreas, progression to autoimmunity and ultimately
destruction of insulin-producing beta cells in the pancreas, result-
ing in dependence on daily exogenous insulin to control blood
glucose levels. T1D is a complex disorder whose etiology is poorly
understood, but it is widely believed that a combination of genetic
and environmental factors contribute to increased T1D risk (Knip
et al., 2005). Disease incidence rate varies dramatically by coun-
try with Finland having the highest known rate (Karvonen et al.,
1993). While genetics explains 50% of T1D risk (Atkinson et al.,
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2014), the acceleration in this disease’s incidence over the last 50
years in developed countries strongly suggests that T1D propen-
sity is increasingly due to environmental factors (Karvonen et al.,
1993).
Evidence from both rodent models and human studies sug-
gests that the composition of the gut microbiome has a significant
influence on the immune system development and may influence
T1D risk. Feeding of antibiotics (Brugman et al., 2006; Schwartz
et al., 2007) or a probiotic-like bacterial strain (Valladares et al.,
2010) reduced autoimmune diabetes in disease-prone rodent
models. Non-obese diabetic (NOD) mice raised in germ-free
environments have an increased risk for diabetes (King and
Sarvetnick, 2011) while exposure to bacterial antigens and infec-
tion decrease T1D risk (Bach, 2002). NOD mice that lack an
adaptor for multiple innate immune receptors have an altered
microbiome compared to control strains (Wen et al., 2008). In
rats with diabetes, a culture-independent study showed increased
proportions of Bacteroides and decreased Lactobacillus, compared
to control rats (Roesch et al., 2009b). In humans, gut micro-
biome analysis of small cohorts of T1D autoimmune and control
children showed significant bacterial taxa and functional dif-
ferences (Brown et al., 2011; Giongo et al., 2011; de Goffau
et al., 2013). More recently, a large case-control study from the
BABYDIET study cohort (Schmid et al., 2004; Hummel et al.,
2011) showed that microbial interaction networks were impaired
in case samples, although no significant differences between
the abundances of bacterial taxa were identified in cases versus
controls (Endesfelder et al., 2014).
The evidence of a microbial role in the development of
Type-1 diabetes lead to the formation of several studies on
human cohorts including TEDDY (TEDDY Study Group, 2008),
BABYDIET, and this study. These studies share several features
including being retrospective, longitudinal across age, and con-
trolling for genotype by selecting only subjects at moderate to
high genetic risk. This study is the largest published study to date
in terms of numbers of samples as well as subjects and is the only
study where all subjects were from the same city and born in the
same hospital thus controlling for many environmental factors
which may confound studies of T1D and the microbiome. Results
reported here from a large Finnish cohort support an association
of a single species of bacteria, Bacteroides dorei, in the devel-
opment of T1D autoimmunity in children at high risk for the
disease. While this association does not establish a causative role
in T1D development, observed changes in the gut microbiome
occurred before development of the disease and could potentially
be used as a biomarker for early screening.
MATERIALS AND METHODS
IRB APPROVAL
Prior to commencing with this work, the University of Florida’s
Institutional Review Board assessed and approved this work as an
exempt project with number 278-2010.
COLLECTION OF STOOL SAMPLES
The Finnish Type 1 Diabetes Prediction and Prevention Study
(DIPP) began genetic screening of newborn infants from the gen-
eral population in 1994 (Nejentsev et al., 1999). Newborns were
screened for high-risk HLA-DR and HLA-DQ genotypes using
a previously described method (Nejentsev et al., 1999). Monthly
stool samples were collected by the subjects’ parents at home and
mailed to the DIPP Virus Laboratory for virology in Tampere,
Finland, where they were stored at −20 to −80◦C. In this study,
76 subjects were retroactively selected to create a cohort of age-
matched genotype-controlled subjects for the investigation of
the microbiome as an environmental factor influencing risk of
autoimmunity.
Subjects were born between 1996 and 2007 at the Turku
University Hospital, Turku located in southwestern Finland
(Table S1). A total of 947 stool samples were collected between
1996 and 2010 at monthly intervals when subjects were between
4–6months old until to 2.2 years old (Table S2). Mode of delivery,
duration of exclusive and total breast feeding, and antibiotics use
were recorded (Tables S1, S4). As all samples were collected from
within 80 km of the Turku University Hospital, the time from
stool collection to frozen storage was likely not long. Previous
work with Turku stool samples has shown minimal change to the
microbial community if frozen within 24 h (Roesch et al., 2009a).
Detection of anti-islet autoimmunity was performed as
described in Parikka et al. (2012). According to the DIPP data
collected by 30 November 2011, the following groups of children
with available stool samples were included in the analyses: cases
(n = 29) who developed at least two persistent T1D-associated
autoantibodies of whom 22 (75%) progressed to T1D later during
the follow-up and clinically unaffected healthy control children
(n = 47) without any auto-antibodies (Table S1). These 47 sub-
jects in the study did not express any islet autoantibodies during
the course of the study and are from here referred to as controls.
Several known confounders of microbiome studies includ-
ing breast feeding (total duration/any), duration exclusive breast
feeding, mode of delivery, and antibiotic use (including amoxi-
cillin and azithromycin, and 7 others) were compared between
case and control groups via the chi-square test (Table S5, see
Supplementary Methods) to ensure that these variables were
balanced between cases and controls.
DNA EXTRACTION, 16S rRNA AND METAGENOMIC SEQUENCING
DNA was extracted from approximately 200-mg of stool sam-
ple usingQiagen AllPrepDNA/RNA/ProteinMini Kit (QIAGEN).
Precautions were taken to avoid contamination, and blank ampli-
fication controls were processed adjacent to samples. DNA
was quantified using a Nanodrop spectrophotometer (Thermo
Scientific, Wilmington, DE). The primers used for 16S rRNA
amplification and subsequent Illumina HiSeq sequencing were
the V3 and V4 universal (Caporaso et al., 2011). For MiSeq
sequencing, the V3 primer was replaced by the 314F primer
(Muyzer et al., 1996). Amplification 16S rRNA gene was per-
formed as described previously (Fagen et al., 2012). PCR reac-
tions were prepared with 25-μl of GoTaq colorless Master Mix
(Promega, Madison, WI), 10-μM of primers, 20-ng of sample
DNA adjusted to 50-μl total volume with sterile, nuclease-free
water. Samples were subjected to an initial denaturation temper-
ature of 95◦C for 3min, followed by 25 cycles of 95◦C for 45 s,
53◦C for 30 s, and 73◦C for 90 s, and a final elongation at 73◦C
for 10min. Amplified DNA was quantified fluorometrically with
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Qubit dsDNAHigh Sensitivity (Invitrogen, Life technologies Inc.,
Carlsbad, CA), and fragment size was verified on a gel. Neither
DNA nor amplification was detected in blank control samples.
Samples were randomly distributed across barcodes, lanes and
sequencing runs to avoid any systematic bias. Equal masses of
DNA from barcoded amplicons were merged and sequenced on
the Illumina HiSeq 2000, and MiSeq platforms (Table S3).
STOOL 16S rRNA SEQUENCING USING 2× 100 bp ILLUMINA HISEQ
A total of 113 gigabases of nucleotide data were generated using
three plates and seven lanes of Illumina HiSeq-2000 sequencing.
Sequences were de-multiplexed based on the barcode sequence
and reads with unmatched barcodes were discarded. Reads were
trimmed for quality to remove bases with a high probability of
error using the program Sickle (Joshi, 2013), and reads containing
ambiguous nucleotides or that were shorter than 70 nucleotides
after trimming were discarded. The 3′-most sequence in each pair
was reverse-complemented so that all sequences were in the 5′–3′
orientation. Removal of low quality bases as well as reads that con-
tained ambiguous nucleotides resulted in an average of 375,313
(SE = 5107) reads per sample with an average length of 98 ±
3 nucleotides. This length is adequate to assign reads to genus
level (Liu et al., 2007). By discarding samples with fewer than
10,000 reads (n = 3) after trimming, 947 samples remained with
a average of 357,581 (SE = 6400) reads per sample.
MICROBIOME 16S rRNA GENE ANALYSIS
To assign and quantify the Operational Taxonomic Units (OTUs)
present in each stool sample, sequences were aligned to the
GreenGenes 97% representatives set version 13.5 (DeSantis et al.,
2006) using the USEARCH program version 6.022 (Edgar, 2010),
a component of QIIME (Caporaso et al., 2010), with 97% min-
imum identity and 95% minimum query coverage. In order
to account for differences in sampling depth, read counts were
subsampled using rarefaction with a sample size of 10,000
reads then divided by the total to calculate the percent relative
abundance.
A total of 335 technical replicates were used to measure vari-
ation due to DNA extraction, amplification and differences in
sequencing run and lane and sequencing technology (Table S3).
Variance of relative abundance within technical replicates was
found to sharply increase as relative abundance decreased (see
Supplementary Methods). This trend was used to define a cutoff
for minimum relative abundance below which accurate estima-
tion of relative abundance is not possible. This cutoff was set at
1% relative abundance and taxa below the 99% most-abundant
taxa were excluded from the analysis due to their having high
variance within technical replicates for DNA extraction, ampli-
fication and sequencing (Tables S6–S8). These filtered taxa made
up a small portion of the total gut microbiome (Figures 1A,B).
However, the total number of taxa including those below the cut-
off was taken into account when performing the false discovery
rate (FDR) correction.
STATISTICAL COMPARISON OF CASE AND CONTROL MICROBIOMES
The relative abundances of taxa at ranks Phylum, Genus, and
Species were compared between all samples from all cases and
controls using the non-parametric Mann–WhitneyU-test (Tables
S6–S8). To adjust for differences in per-subject sampling fre-
quency, p-values were averaged over 100 bootstrap iterations
with even per-subject sampling frequency and bootstrapped p-
values were adjusted for FDR using the B-H method (Benjamini
and Hochberg, 1995) using the total number of taxa including
those that fell below 1% average relative abundance. Significance
was considered if the adjusted, bootstrapped p-value fell below
alpha = 0.001.
Logistic regression was used to model the interaction of
age and relative abundance of each taxon with seroconver-
sion as the response variable and model terms were tested
for significant association with seroconversion. In this case,
the model terms were the interaction between age and rel-
ative abundance. Significance of model terms was tested for
using ANOVA. Model terms that fit significantly to seroconver-
sion can be said to significantly vary between cases and con-
trols. FDR-correction was applied to p-values using the same
method as the Mann-Whitney U test. The relative abundances of
significant taxa were visualized across age using LOESS regression
(Figure 2).
FIGURE 1 | The gut microbiome had low diversity and was dominated
by a few taxa with median relative abundances greater than 1%. (A)
The most abundant phyla were Bacteroidetes and Firmicutes followed by
Proteobacteria and Actinobacteria. (B) The most abundant genus was by far
Bacteroides followed by Ruminococcus, Faecalibacterium, Blautia,
Bifidobacterium Veillonella and Coprococcus. While a large number of
species were detected, the majority of these had very low relative
abundance.
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FIGURE 2 | Development of the microbiome differed between cases and
controls at the (A) Phylum, (B) Genus and (C) Species ranks across age.
Plotted are significant taxa with median relative abundance greater than 1%.
Shaded region represents standard error of a LOESS smoothing regression.
Vertical lines represent the median (solid) and standard error (dashed) age of
appearance of first the autoantibody in cases.
METAGENOMIC SEQUENCING OF SAMPLES ENRICHED FOR
Bacteroides dorei
DNA samples with a Bacteroides abundance above 47%, as mea-
sured by 16S rRNA analysis, were sequenced by the Pacific
Bioscience RS-II platform with data assembled and analyzed as
described previously (Leonard et al., 2014). Two of these four
metagenomes used in this work were closed previously (Leonard
et al., 2014, NCBI accession numbers CP007619 and CP008741).
A third closed B. dorei genome is described here (NCBI accession
number CP009057) which was obtained in the samemanner from
a healthy child, sample number 728. A fourth metagenome from
a case subject, sample number 233 resulted in a partially assem-
bled B. dorei genome. All four metagenomes were mined for 16S
and 23S rRNA using RNAmmer (Lagesen et al., 2007), as well as
for a beta-glucosidase gene that has been reported to be present
in B. dorei but lacking in B. vulgatus (Pedersen et al., 2013).
The 16S and 23S rRNA sequences mined from the metage-
nomic DNA were combined with sequences from Bacteroides
species using Prevotella as an outgroup, aligned using MUSCLE
and used to generate phylogenetic trees with PhyML using a
GTR model (Figure 3A). These trees had nodes with higher
(greater than 0.80) bootstrap support value and were capable of
confidently separating B. dorei from B. vulgatus.
IDENTIFICATION OF Bacteroides dorei AS THE MAIN COMPONENT OF
THE Bacteroides dorei/vulgatus GROUP
The length of the 2 × 100 bp Illumina HiSeq reads was insuffi-
cient to accurately distinguish B. dorei from B. vulgatus (Figure
S1). Additional sequencing with overlapping 2 × 350 bp reads
on the Illumina MiSeq platform to obtain assembled 450 bp
reads was conducted on a set of 93 samples with >10% rela-
tive abundance of Bacteroides to improve taxonomic resolution
of the B. dorei/B. vulgatus group. Reads were generated using
a different forward primer (Muyzer et al., 1996), that targeted
the 314–357 F region of the 16S rRNA gene. Overlapping MiSeq
reads were assembled into single contigs using Pandaseq (Masella
et al., 2012) and filtered to include only reads longer than 450 bp.
Assembled MiSeq reads were trimmed to exactly 450 bp. A sub-
set of 10,000 reads from each sample were clustered using de novo
clustering at 99.6% identity by UCLUST (Edgar, 2010) to iden-
tify representative taxa. Representative sequences were combined
with truncated 16S rRNA sequences from known Bacteroides
species from GreenGenes and 16S rRNA sequences from the four
PacBio metagenomes, aligned with MUSCLE (Edgar, 2004), and
used to create a phylogenetic tree using PhyML with the GTR
model (Guindon et al., 2005). A high bootstrap value (0.89)
was measured in the branch separating B. dorei and B. vulga-
tus (Figure 3C). Representative sequences were then re-labeled
as B. dorei and B. vulgatus depending on their placement in
the phylogenetic tree and used as references to align the MiSeq
reads to estimate relative abundance of the two groups and com-
pared to the combined B. dorei and B. vuglatus relative abundance
obtained from shorter reads.
Poisson linear regression was used to estimate the relative
abundance of B. dorei and B. vulgatus based on the correlation
between HiSeq relative abundance of the B. dorei/vulgatus group
and MiSeq relative abundance of B. dorei and B. vulgatus sepa-
rately (see Supplementary Methods). Samples were up-weighted
based on relative abundance due to their measured increase in
variance resulting in linear regressions with good fit (R2 = 0.94).
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FIGURE 3 | (A) Longer 16S rRNA MiSeq reads separated Bacteroides
dorei from B. vulgatus. (B) Comparison of full-length 16S and (C) 23S
rRNA genes from closed and partially closed B. dorei genomes from
stool shotgun metagenomes identified the B. dorei/vulgatus group as
B. dorei. and (D) B. dorei/vulgatus group appears to be dominated by
B. dorei.
Fitted linear regressions were then used to estimate B. dorei and
B. vulgatus relative abundance for the remaining samples based
on HiSeq data (Figure 2D).
DETERMINING TIMING OF Bacteroides dorei SPIKE
To determine the specific timing of the B. dorei spike in cases,
samples were binned into windows across age with average width
of 98 days (SE = 0.33), two samples per individual and 98 sam-
ples per window (SE = 2.98). Windows with less than 20 cases
and 20 controls were discarded. Downsampling was used to
account for differences in subject sampling frequency by taking
the median relative abundance for each taxon frommultiple sam-
ples from the same individual. Bootstrapping was used to account
for differences in sampling frequency between cases and controls
averaging Mann-Whitney U p-values over 100 bootstraps within
each window (Figure 3, Table S5).
ESTIMATION OF ABSOLUTE Bacteroides dorei ABUNDANCE
Sequencing of 16S rRNA amplicons can only measure relative
(proportion of the total) abundance. Therefore, the spike in
relative abundance of B. dorei could be either a true spike in
number of B. dorei cells or a decrease in the abundance of all
other taxa. This leaves two possibilities, either B. dorei is asso-
ciated with disease or the reduction in all of the other bacterial
inhabitants are associated with disease but B. dorei remains. The
total abundance of B. dorei was measured in order to distinguish
the two possibilities. SYBR Green Quantitative PCR (qPCR) was
used to estimate absolute abundance of the Bacteroides group
using Bacteroides-specific primers that were shown to have high
sensitivity and specificity (Liu et al., 2003). Twenty-eight samples
taken from subjects between the age of 200 and 350 days were
chosen based on (1) equal number of cases and controls; (2) good
representation of the range of relative abundances; and (3) high
DNA concentration (20 ng/uL). Amplification of a standard curve
of PCR product generated from Bacteroides fragilis ATCC 25285
cDNA using the same primers in triplicate was used to calculate
copy number in the stool DNA. Six samples were thrown out due
to having high intra-triplicate variance. Relative abundance and
absolute abundance were highly correlated using a Poisson linear
regression (p = 2.18 × 10−35, see Supplementary Methods).
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PREDICTING SEROCONVERSION BASED ON Bacteroides dorei
RELATIVE ABUNDANCE
The accuracy of a logistic regression model to measure the accu-
racy of predicting seroconversion based on the relative abundance
of B. dorei was estimated using leave-one-subject-out cross-
validation (Table S5). Because of the possibility of the logistic
regression classifying a subject as case or control could depend on
recognition of that subject’s microbiome rather than true differ-
ences between cases and controls, relative abundances were down-
sampled per subject and no sample from the same subject was
used for training and testing. Cross-validation accuracy was mea-
sured using the Area Under the receiver operating Characteristic
(AUC) with significance being measured using an analysis of
variance with a chi-squared test (Table S5).
AVAILABILITY OF SOURCE CODE AND DATA
Source code used for the statistical analyses is available
at https://github.com/triplett/dipp-microbiome-study. The 16S
rRNA sequencing reads for this work are archived in NCBI
BioProject PRJNA232731. The B. dorei genome sequenced in
this study (from sample 728) is available under the NCBI acces-
sion CP009057. The Illumina HiSeq and MiSeq 16S sequences
are available from NCBI’s Short Read Archive under Study
SRP043574. Table S10 contains a table of unrarefied 16S rRNA
read counts at Phylum, Genus and Species ranks.
Analyses were performed using functions in the R program-
ming language (R Core Team, 2012) as well as the Phyloseq
(McMurdie and Holmes, 2012) and ggplot2 (Wickham, 2009).
RESULTS
To examine the development of the gut microbiome in children
at genetic risk for type 1 diabetes (T1D), DNA from 947 stool
samples from 76 number children having the moderate (odds-
ratio <5) to high risk (odds-ratio 5–15) for T1D according to
their HLA-DQB1 genotype, which is known to increase T1D
risk, was sequenced. The HLA-DQ genotype is the most com-
mon high-risk genotype for T1D and confers a greater risk for
future T1D than other high-risk alleles (Barrett et al., 2009).
Twenty-nine subjects developed at least three persistent T1D-
relative autoantibodies (mean age at diagnosis = 16.8 months,
SE = 2.03), which collectively confers >95% risk of clinical
T1D diagnosis. Those 29 subjects are considered “cases” for
the purposes of this study. The remaining 47 subjects with no
detectable T1D-related autoantibodies in serum were retroac-
tively selected to serve as “controls” (Table S1). Genetic risk for
T1D was balanced between case and control groups leaving the
remaining risk up to environmental factors. To better control for
environmental variables other than the gut microbiome includ-
ing factors which are known to effect the microbiome such as
mode of delivery (Dominguez-Bello et al., 2010), breast feed-
ing (Cabrera-Rubio et al., 2012), and antibiotics (Dethlefsen
et al., 2008; Jakobsson et al., 2010; Panda et al., 2014), sub-
jects recruited for the retrospective, longitudinal DIPP study
were examined for differences in these factors. None of these
factors were significantly different between cases and controls
(p > 0.05, see Supplementary Methods). No information on
introduction of solid food was collected. However, months of
exclusive breast feeding did not differ between cases and con-
trols. All subjects were born in the Turku University Hospital
in Turku, Finland allowing us to specifically examine differ-
ences in the gut microbiome compositions of individuals pro-
gressing to T1D-related autoimmunity vs. those not developing
T1D-autoimmunity, while controlling for other environmental
factors.
GUT MICROBIOME DIFFERS BETWEEN CASES AND CONTROLS BEFORE
SEROCONVERSION
To determine the extent to which gut bacterial communities
may differ between genetically at-risk subjects progressing toward
T1D and those avoiding T1D progression, bacterial commu-
nity 16S rRNA genes were sequenced from 947 stool sam-
ples collected every 36 days (SE = 11) on average (Table S2)
and were assigned sequences to “operational taxonomic units”
(OTUs) in order to characterize the taxonomic composition
of each sample’s community. At the phylum level, the gut
microbiomes were dominated by Bacteroidetes and Firmicutes
followed by Actinobacteria and Proteobacteria (Figure 1A). At
the genus level, these samples were high in relative abundance
of Bacteroides(30–50%) followed by moderate levels(<10%)
of Ruminococcus, Faecalibacterium, Blautia, Bifidobacterium,
Veillonella, and Coprococcus (Figure 1B). Taxa below 1% median
relative abundance were filtered from the analysis as the abun-
dance measurement of these taxa was unreliable in technical
replicates (see Supplementary Methods). The remaining domi-
nant taxa made up the vast the majority of the net microbial
community consistent with previous studies on the human gut
microbiomes of healthy and at-risk humans (Brown et al., 2011;
Giongo et al., 2011; Kraal et al., 2014).
Gut microbiomes were compared between cases and controls
by testing for differences in relative abundance across all samples
and across age (see methods). All statistical tests were adjusted for
false discovery rate, a common problem in studies with a high-
number of variables. Taxa below 1% were included in the FDR
correction. Microbiome differences were only considered signif-
icant if their adjusted p-values fell below an alpha level of 0.001.
This approach is likely to make our approach conservative, while
focusing on the high-abundance taxa more likely to have large
effects on biological processes in the human gut.
Across all samples, the Gram-negative phylum Bacteroidetes
was on average 6.7% higher in cases than controls (adjusted
p = 2.17e-6) and the Gram-positive phyla Proteobacteria and
Tenericutes were significantly higher in controls (adjusted p =
1.59e-7 and 7.20e-8 respectively). Comparison of the gut micro-
biome across age at showed only Bacteroidetes and Firmicutes to
be significantly different between cases and controls (Figure 1A,
adjusted p-values= 1.35e-10, 2.2e-5, respectively). Further exam-
ination of the gut microbiome communities of cases vs. controls
revealed that a single dominant genus Bacteroides was signifi-
cantly higher in cases vs. controls using all samples at all time
points with a median relative abundance of 44.4% in cases (SE =
5.5 × 10−3) and 30.7% (SE = 10.2 × 10−3) in controls (adjusted
p = 1.6e0-7). Bacteroides and Coprococcus were found to vary
significantly across age (Figure 2B, adjusted p-values = 3.6e-11,
8.5e-05, respectively) although Coprococcus was only significantly
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higher in controls at a higher alpha considered in this study
(adjusted p = 0.034).
The Bacteroides genus was found to be dominated by two
closely related species, Bacteroides dorei and Bacteroides vulgatus,
which differed significantly between cases and controls across all
samples, across age (p = 1.78e-17, Table S3) and within several
windows prior to seroconversion (Figure 1C, p < 0.01, Table S5).
These two species were not distinguishable by their V4 16S rRNA
region preventing further identification (see methods). Longer
sequencing of the combined V3 and V4 regions in 93 samples
differentiated the two species identifying B. dorei as the major
constituent and both B. dorei and B. vulgatus (Figure 3C).
To provide further evidence of the identity of the
B. dorei/vulgatus group as B. dorei, we performed shotgun
metagenomic sequencing on four stool samples and succeeded
in the closure of three genomes closely resembling B. dorei, two
of which we reported previously (Leonard et al., 2014). These
genomes had higher average nucleotide identity to B. dorei than
B. vulgatus, as well as a beta-galactosidase gene which B. vulgatus
lacks (Bakir et al., 2006). Assembly of the fourth genome did not
result in genome closure. However, full-length 16S and 23S rRNA
genes mined from all four samples clustered at high confidence
with B. dorei on a phylogenetic reconstruction (Figures 3A,B).
Relative abundance of B. dorei in these metagenomes closely
matched that measured by 16S rRNA sequences (R2 = 0.97,
Table S9).
B. dorei made up roughly 75% of the B. dorei/vulgatus group
(Figure 3D, see methods) and was significantly higher in cases
across age using the logistic regression approach (p < 0.001).
B. dorei was 5 times more abundant in cases than controls across
all samples and reached up to 100 times higher in cases (17.3%
relative abundance, SE = 0.02) versus controls (0.18%, SE =
0.01) within a 78-day window at 7.5 month of age, or 9.2 months
prior to the average age of first T1D autoantibody (p = 0.005,
Figure 4, Table S5).
High-throughput sequencing is limited by its ability to only
measure relative as opposed to absolute abundance. As a result,
an apparent increase in the relative abundance of a taxon could
be the result of either an actual increase in absolute abundance of
that taxon or a decrease in all remaining taxa. To overcome this
limitation, quantitative PCR was done on 22 stool DNA samples
using universal Bacteroides-specific primers. The relative abun-
dance of Bacteroides was highly correlated with absolute abun-
dance (see Supplementary Methods). Therefore, this increase in
B. dorei is likely due to an increase in actual number of cells, not
a decrease in all other taxa.
To test whether the B. dorei can be used as a biomarker to pre-
dict future autoimmunity and type-1 diabetes, we tested efficacy
of classification of case/control status based on B. dorei abundance
using cross-validation, which estimates a predictor’s accuracy
on real-world data. Cross-validation was performed using the
sliding window across age and accuracy was found to peak in
samples taken between 6.1 and 12.1 months of age, between 12
and 15 months before the first detection of T1D autoimmunity
(Figure 5, Table S5). Accuracy measured by the Area Under the
Curve (AUC) to be 0.69 (SE = 0.007) which was significantly
higher than chance (p = 0.019, Figures 4, 5, Table S5) using data
downsampled by subject in order to avoid overfitting to subjects’
microbiomes. However, a true, blind leave-out dataset is required
in order to measure the accuracy of microbiome-based prediction
of autoimmunity on real-world data (Babyak, 2004).
DISCUSSION
In this cohort, high levels of Bacteroides dorei in the gut are
associated with future autoimmunity for T1D. Bacteroides dorei
is a recently discovered species isolated from the human gut
FIGURE 4 | Sliding window analysis showed Bacteroides dorei being
significantly higher in cases prior to seroconversion at around 7.6
months of age. Vertical bars along the bottom of the x-axis represent median
subject age in windows with significantly different relative abundance
between cases and controls at alpha levels 0.05 (green) and 0.01 (blue) as
determined by the Mann–Whitney test. Relative abundance was
downsampled by subject within each window to prevent one subject’s
microbiome from dominating the results.
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FIGURE 5 | Bacteroides dorei/vulgatus predicts autoimmunity before
appearance of any single autoantibody. Timing of prediction of
autoimmunity. Blue line represents median age (11 months) of subjects in
windows of samples taken from subjects aged 6.1–12.1 months with
standard error lines (dashed). The purple line represents median age of the
appearance of the first autoantibody with standard error lines (dashed). The
proportion of cases who have seroconverted is plotted across time (orange
area). Estimation of the efficacy of B. dorei to serve as a predictor of future
autoimmunity was significantly better than chance within this window (AUC
= 0.68, SE = 0.007) before the appearance of any single autoantibody.
(Bakir et al., 2006) and may be mistaken with B. vulgatus due to
their taxonomic similarity (Bakir et al., 2006). However, whole
genome analysis shows that the two species are sufficiently differ-
ent to warrant separate species designations. Nevertheless, the two
species are very similar and have not yet been distinguished from
each other physiologically apart from beta-galactosidase activity
in B. dorei (Bakir et al., 2006).
Higher levels of Bacteroides in cases were observed previously
in a rat model for T1D as well as in human cohorts (Roesch
et al., 2009b; Brown et al., 2011; Giongo et al., 2011). However,
this work advances our knowledge in three ways. First, it is the
largest human T1D cohort examined to date and is a cohort
derived from a single city with all children born in the same hos-
pital. Second, a frequent sampling of the subjects occurred from
about 6 months after birth until 3 years of age, which provides the
ability to observe the development of the microbiome across age
and identify potential associations. And third, the analyses per-
formed here suggest a role for a single, dominant bacterial species
associated with T1D autoimmunity.
Increased abundance of Bacteroides species including B. dorei
and B. vulgatus have been implicated in inflammation in several
gut diseases such as ulcerative colitis (UC), irritable bowel disease
(IBD), and celiac disease (CD) (Breeling et al., 1988; Rath et al.,
1999; Fujita et al., 2002; Sanchez et al., 2010, 2011; Sato et al.,
2010; Schippa et al., 2010; Bloom et al., 2011). A recent report
showed that B. vulgatus was found in duodenal biopsy specimens
of 70% of subjects (14 of 20) with untreated CD versus 0% of
subjects (0 of 12) treated with a gluten-free diet for at least two
years (Schippa et al., 2010).
While it has not been shown whether B. vulgatus or B. dorei are
causative rather than correlated with disease, B. vulgatus induces
colitis in rats, mice, and guinea pigs (Salyers et al., 1977; Fujita
et al., 2002; Sanchez et al., 2011). Strains of B. vulgatus asso-
ciated with human UC have a rougher surface and higher cell
adherence rates than B. vulgatus strains derived from non-UC
patients (Schippa et al., 2010). B. vulgatus is not thought to
directly cause IBD but may prevent its remission (Fujita et al.,
2002) and is also known as an opportunistic pathogen caus-
ing intra-abdominal infections (Rath et al., 1999). Infants with
high-risk HLA genotypes for T1D and CD had higher prevalence
of B. vulgatus than infants at low genetic risk (Sanchez et al.,
2011). B. vulgatus was more common in CD patients, and B. dorei
was more common in patients with active CD (Sanchez et al.,
2010).
The cause of increased B. dorei in these subjects is not known.
Bacteroides are observed in infants after the first introduction of
solid food (Nwaru et al., 2010). Bacteroides colonization of the
human gut at this early stage of life is important given their role
in the digestion of complex carbohydrates (Salyers et al., 1977).
At the time of the infant period for the current study partici-
pants, the national health care system in Finland recommended
that parents should introduce solid food between the age of 4 and
6 months (Simell and Aula, 1997; Hasunen et al., 2004). Thus, the
appearance of a large proportion of Bacteroides in these children
at 6 months of age appears to be associated with the introduction
of solid food.
Bacteroides possess high numbers of antibiotics resistance
genes. It is possible that the increase in antibiotic usage, espe-
cially in developed countries, has led to an overall increase in
Bacteroides across entire populations and in their environment.
This might explain the recent increase in T1D prevalence as well
as country-by-country differences. This study lacks sufficient data
to estimate the effect of antibiotics on Bacteroides abundance in
the gut and risk for autoimmunity and T1D. Larger cohorts with
an antibiotic control group are needed to investigate this potential
link.
Whether B. dorei plays a role in causing T1D autoimmu-
nity in these children or is simply a consequence of emerging
autoimmunity, overall health, or yet another environmental fac-
tor is unknown. If B. dorei is involved in he development of
autoimmunity, likely routes include disruption of the epithelial
layer and/or manipulation of immune system development. If
this is the case, can high levels of B. dorei gut colonization be
prevented? Bacteroides strains are resistant to antibiotics com-
monly used in pediatrics such as amoxicillin. The B. dorei genome
sequenced from these stool samples possesses over 50 genes anno-
tated as antibiotic resistance determinants (Leonard et al., 2014).
However, two antibiotics, doripenem and tigecycline, are both
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injected to treat intra-abdominal infections caused by B. dorei
(Brook et al., 2013). Whether they would be useful in reducing
B. dorei gut colonization through oral administration is unclear.
Alternatively, Bifidobacterium strains decrease the population of
B. vulgatus in the gut (Shiba et al., 2003) and ameliorate gut
inflammation by reducing B. vulgatus gut populations of gnoto-
biotic mice (Setoyama et al., 2003).
Another possibility is that a diet change could reduce the
population size of B. dorei. Previous work has shown that the
proportion of children with B. vulgatus or B. dorei in the gut
declines when a gluten-free diet is introduced after diagnosis of
celiac disease (Sanchez et al., 2010). In addition, the gut micro-
biome of children at high risk for celiac disease are more likely
to include B. dorei or B. vulgatus than the microbiomes of low
risk children (Sanchez et al., 2011). In addition, high protein
and fat diets are correlated with high Bacteroides populations
(Wu et al., 2011).
Results presented here show that the microbiome differs
within a window of several months preceding the appearance of
the first anti-islet autoantibodies. As such, even if B. dorei is not
the cause of T1D autoimmunity, its abundance in the gut may
be useful as a diagnostic in high-risk groups, such as first-degree
relatives, at 6–8 months of age, prior to the appearance of a sin-
gle autoantibody. At present, infants are not commonly screened
for their HLA genotype at birth. Hence, a child’s high genetic risk
for T1D is only easily determined by the parents if the child has a
first degree relative with the disease. As our knowledge of micro-
biome associations with T1D expands, gut microbiome test-
ing through non-invasive stool analysis might be recommended
in the future for infants with a first degree relative affected
by T1D.
Type 1 diabetes is a complex disease and is thought to be a
cluster of similar diseases with different etiologies (Knip et al.,
2005). Studying multiple forms of a disease as a whole may mask
differences specific to a single sub-type and fail to discover novel
associations. For example, in the BABYDIET study (Endesfelder
et al., 2014), which examined the development microbiomes of
children from across Germany, no associations were found. In
this study, all subjects were born in the same hospital in Turku,
Finland and remained in Turku and surrounding areas for the
study’s duration. As a result, many factors are very similar for
all Turku children across this cohort such as climate, health
standards and practices, quality of drinking water, exposure to
environmental pollutants, diet, and vitamin D levels from sun
exposure. Controlling of all of these environmental factors may
increase the likelihood that subjects who develop type-1 diabetes
have the same form of the disease with the same etiology. Thus,
studying large cohorts from one city or small geographic region
is particularly valuable.
Bacteroides dorei may or may not be associated with T1D
autoimmunity in other disease forms, which are more prevalent
in other locations. Alternatively, and perhaps more likely, the key
to understanding the role of the microbiome in T1D may not be
the identification of a specific bacterium, but a set of specific bac-
terial genes related to gut health. It just so happens, that in this
one city, Turku, Finland, those functionsmay largely be associated
with one bacterial species.
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